BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 37713135)

  • 1. Preclinical pediatric brain tumor models for immunotherapy: Hurdles and a way forward.
    Mishra DK; Popovski D; Morris SM; Bondoc A; Senthil Kumar S; Girard EJ; Rutka J; Fouladi M; Huang A; Olson JM; Drissi R
    Neuro Oncol; 2024 Feb; 26(2):226-235. PubMed ID: 37713135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for Pediatric Brain and Spine Tumors: Current State and Future Directions.
    Estevez-Ordonez D; Gary SE; Atchley TJ; Maleknia PD; George JA; Laskay NMB; Gross EG; Devulapalli RK; Johnston JM
    Pediatr Neurosurg; 2023; 58(5):313-336. PubMed ID: 36549282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unique immune ecosystems in pediatric brain tumors: integrating single-cell and bulk RNA-sequencing.
    Cao L; Xie W; Ma W; Zhao H; Wang J; Liang Z; Tian S; Wang B; Ma J
    Front Immunol; 2023; 14():1238684. PubMed ID: 38094301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current landscape of immunotherapy for pediatric brain tumors.
    Hwang EI; Sayour EJ; Flores CT; Grant G; Wechsler-Reya R; Hoang-Minh LB; Kieran MW; Salcido J; Prins RM; Figg JW; Platten M; Candelario KM; Hale PG; Blatt JE; Governale LS; Okada H; Mitchell DA; Pollack IF
    Nat Cancer; 2022 Jan; 3(1):11-24. PubMed ID: 35121998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
    Medikonda R; Pant A; Lim M
    Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards Immunotherapy for Pediatric Brain Tumors.
    Wang SS; Bandopadhayay P; Jenkins MR
    Trends Immunol; 2019 Aug; 40(8):748-761. PubMed ID: 31229353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospect of Immunotherapy for Glioblastoma: Tumor Vaccine, Immune Checkpoint Inhibitors and Combination Therapy.
    Ishikawa E; Yamamoto T; Matsumura A
    Neurol Med Chir (Tokyo); 2017 Jul; 57(7):321-330. PubMed ID: 28539528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Brain Tumours: Lessons from the Immune Microenvironment.
    Yao B; Delaidelli A; Vogel H; Sorensen PH
    Curr Oncol; 2023 May; 30(5):5024-5046. PubMed ID: 37232837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-cellular immunotherapies in pediatric central nervous system tumors.
    Rumler S
    Front Immunol; 2023; 14():1242911. PubMed ID: 37885882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploitation of immune mechanisms in the treatment of central nervous system cancer.
    Pollack IF; Okada H; Chambers WH
    Semin Pediatr Neurol; 2000 Jun; 7(2):131-43. PubMed ID: 10914414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune profiling of pediatric solid tumors.
    Terry RL; Meyran D; Ziegler DS; Haber M; Ekert PG; Trapani JA; Neeson PJ
    J Clin Invest; 2020 Jul; 130(7):3391-3402. PubMed ID: 32538896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Checkpoint Proteins in Pediatric Brain and Extracranial Solid Tumors: Opportunities for Immunotherapy.
    Ring EK; Markert JM; Gillespie GY; Friedman GK
    Clin Cancer Res; 2017 Jan; 23(2):342-350. PubMed ID: 27836863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatments for astrocytic tumors in children: current and emerging strategies.
    Burzynski SR
    Paediatr Drugs; 2006; 8(3):167-78. PubMed ID: 16774296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials in cellular immunotherapy for brain/CNS tumors.
    Badhiwala J; Decker WK; Berens ME; Bhardwaj RD
    Expert Rev Neurother; 2013 Apr; 13(4):405-24. PubMed ID: 23545055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immunotherapy for pediatric solid tumors.
    Hegde M; Moll AJ; Byrd TT; Louis CU; Ahmed N
    Cytotherapy; 2015 Jan; 17(1):3-17. PubMed ID: 25082406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma.
    Shen S; Chen L; Liu J; Yang L; Zhang M; Wang L; Zhang R; Uemura Y; Wu Q; Yu X; Liu T
    Cancer Biol Med; 2020 Aug; 17(3):555-568. PubMed ID: 32944390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy Approaches for Pediatric CNS Tumors and Associated Neurotoxicity.
    Finch EA; Duke E; Hwang EI; Packer RJ
    Pediatr Neurol; 2020 Jun; 107():7-15. PubMed ID: 32113728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors.
    Melaiu O; Lucarini V; Giovannoni R; Fruci D; Gemignani F
    Semin Cancer Biol; 2022 Feb; 79():18-43. PubMed ID: 32659257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.